These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 33432113)

  • 21. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
    Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
    J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deubiquitinating enzymes and the proteasome regulate preferential sets of ubiquitin substrates.
    Trulsson F; Akimov V; Robu M; van Overbeek N; Berrocal DAP; Shah RG; Cox J; Shah GM; Blagoev B; Vertegaal ACO
    Nat Commun; 2022 May; 13(1):2736. PubMed ID: 35585066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitination: Friend and foe in cancer.
    Mansour MA
    Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.
    Voutsadakis IA
    Tumour Biol; 2012 Aug; 33(4):897-910. PubMed ID: 22399444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?
    Zhao CX; Zeng CM; Wang K; He QJ; Yang B; Zhou FF; Zhu H
    Acta Pharmacol Sin; 2021 Feb; 42(2):179-188. PubMed ID: 32601365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of allostery in the ubiquitin-proteasome system.
    Liu J; Nussinov R
    Crit Rev Biochem Mol Biol; 2013; 48(2):89-97. PubMed ID: 23234564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
    Villeneuve NF; Lau A; Zhang DD
    Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the ubiquitin pathway for cancer treatment.
    Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
    Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linear ubiquitination at a glance.
    Spit M; Rieser E; Walczak H
    J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30659056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
    Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
    Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
    Nguyen HC; Wang W; Xiong Y
    Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimerization regulates the human APC/C-associated ubiquitin-conjugating enzyme UBE2S.
    Liess AKL; Kucerova A; Schweimer K; Schlesinger D; Dybkov O; Urlaub H; Mansfeld J; Lorenz S
    Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating the Regulators: Recent Revelations in the Control of E3 Ubiquitin Ligases.
    Vittal V; Stewart MD; Brzovic PS; Klevit RE
    J Biol Chem; 2015 Aug; 290(35):21244-51. PubMed ID: 26187467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human disorders of ubiquitination and proteasomal degradation.
    Jiang YH; Beaudet AL
    Curr Opin Pediatr; 2004 Aug; 16(4):419-26. PubMed ID: 15273504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs.
    Evans PC
    Expert Rev Mol Med; 2005 Jun; 7(12):1-19. PubMed ID: 15967057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.